Inflammatory pathway mediators

Inflammatory pathway mediators are a diverse group of endogenous signaling molecules that initiate, regulate, and resolve the inflammatory response (Creative BioMart, https://www.creativebiomart.net/resource/library-inflammatory-mediators-different-diseases.htm). This broad category includes cytokines such as TNF-alpha, IL-1, and IL-6, chemokines, lipid mediators like prostaglandins and leukotrienes, vasoactive amines such as histamine, and various enzymes and transcription factors (StudySmarter, https://www.studysmarter.co.uk/explanations/biology/immune-system/inflammatory-mediators/). These molecules are produced by immune cells and other tissues in response to injury or infection, facilitating the recruitment of leukocytes and the activation of defense mechanisms (Wyndly, https://www.wyndly.com/blogs/learn/inflammatory-mediators). While essential for host defense and tissue repair, the dysregulation or chronic production of these mediators is a hallmark of numerous inflammatory and autoimmune diseases, including rheumatoid arthritis, asthma, and inflammatory bowel disease (NIH, https://pmc.ncbi.nlm.nih.gov/articles/PMC7122703/). Consequently, many therapeutic strategies focus on neutralizing specific mediators or inhibiting their production to alleviate symptoms and prevent tissue damage (MDPI, https://www.mdpi.com/2073-4409/12/24/2861). Because this term encompasses a wide range of distinct molecular targets, it is typically used as a functional classification rather than a single therapeutic entity.

Other names

Inflammatory mediatorsChemical mediators of inflammationPro-inflammatory mediatorsInflammatory signaling molecules

Inhibition of specific cytokines (e.g., TNF-alpha, IL-6), enzymes (e.g., COX-1, COX-2), or receptors (e.g., H1, leukotriene receptors) to modulate the inflammatory cascade (Fiveable, https://fiveable.me/ap-biology/unit-2-cell-structure-function/cell-communication/study-guide).